Enero Group (EGG) H2 2025 earnings summary

Executive summary

• Revenue and EBITDA grew in the Technology, Healthcare & Consumer (THC) Practice, with improved margins in the second half of FY25 despite a challenging start to the year.

• OBMedia was divested on 30 June 2025, allowing management to focus on core agencies and shareholder value.

• Corporate costs were reduced in H2, and the business maintained a net cash position of $27.5m with low debt.

Financial highlights

• Net revenue from continuing operations declined 3% year-over-year to $138.7m, impacted by macroeconomic and tech sector headwinds.

• EBITDA from continuing operations rose 2% to $14.1m, with margin up 0.5ppt to 10.2%.

• Adjusted net profit attributable to equity owners was $4.2m, flat year-over-year.

• Dividend per share was 2.8 cents, down 44% from the prior year.

• Free cash flow was $8.8m, with cash conversion at 79% of EBITDA.

Outlook and guidance

• Ongoing focus on value creation through AI, automation, and operational efficiency.

• Continued cost initiatives expected to deliver further savings in FY26.

• Final contingent consideration payment for ROI-DNA due in FY26 H1.